Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Aprea Therapeutics Q3 EPS $(0.86) Beats $(1.16) Estimate, Sales $319.47K Beat $80.00K Estimate

Author: Benzinga Newsdesk | November 09, 2023 06:27pm

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(1.16) by 25.86 percent. This is a 64.17 percent increase over losses of $(2.40) per share from the same period last year. The company reported quarterly sales of $319.47 thousand which beat the analyst consensus estimate of $80.00 thousand by 299.34 percent.

Posted In: APRE